These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 28419994

  • 1. Degradation of Mcl-1 through GSK-3β Activation Regulates Apoptosis Induced by Bufalin in Non-Small Cell Lung Cancer H1975 Cells.
    Kang XH, Zhang JH, Zhang QQ, Cui YH, Wang Y, Kou WZ, Miao ZH, Lu P, Wang LF, Xu ZY, Cao F.
    Cell Physiol Biochem; 2017; 41(5):2067-2076. PubMed ID: 28419994
    [Abstract] [Full Text] [Related]

  • 2. Degradation of MCL-1 by bufalin reverses acquired resistance to osimertinib in EGFR-mutant lung cancer.
    Cao F, Gong YB, Kang XH, Lu ZH, Wang Y, Zhao KL, Miao ZH, Liao MJ, Xu ZY.
    Toxicol Appl Pharmacol; 2019 Sep 15; 379():114662. PubMed ID: 31301315
    [Abstract] [Full Text] [Related]

  • 3. Caspase cleavage of Mcl-1 impairs its anti-apoptotic activity and proteasomal degradation in non-small lung cancer cells.
    Wang T, Yang Z, Zhang Y, Zhang X, Wang L, Zhang S, Jia L.
    Apoptosis; 2018 Jan 15; 23(1):54-64. PubMed ID: 29256070
    [Abstract] [Full Text] [Related]

  • 4. KRIBB11 accelerates Mcl-1 degradation through an HSF1-independent, Mule-dependent pathway in A549 non-small cell lung cancer cells.
    Kang MJ, Yun HH, Lee JH.
    Biochem Biophys Res Commun; 2017 Oct 21; 492(3):304-309. PubMed ID: 28859986
    [Abstract] [Full Text] [Related]

  • 5. Renieramycin T Induces Lung Cancer Cell Apoptosis by Targeting Mcl-1 Degradation: A New Insight in the Mechanism of Action.
    Petsri K, Chamni S, Suwanborirux K, Saito N, Chanvorachote P.
    Mar Drugs; 2019 May 21; 17(5):. PubMed ID: 31117253
    [Abstract] [Full Text] [Related]

  • 6. DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors.
    Li Y, Zhou D, Xu S, Rao M, Zhang Z, Wu L, Zhang C, Lin N.
    Cancer Biol Med; 2020 May 15; 17(2):387-400. PubMed ID: 32587776
    [Abstract] [Full Text] [Related]

  • 7. [Effect of bufalin combined gefitinib on lung cancer H1975 cells and its mechanisms research].
    Kang XH, Gong YB, Wang LF, Wang ZQ, Deng HB, Zhao XZ, Wu J, Xu ZY.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Aug 15; 33(8):1081-5. PubMed ID: 24325059
    [Abstract] [Full Text] [Related]

  • 8. Knockdown of miR-15b partially reverses the cisplatin resistance of NSCLC through the GSK-3β/MCL-1 pathway.
    Lu T, Lu W, Jia C, Lou S, Zhang Y.
    Adv Clin Exp Med; 2021 Aug 15; 30(8):849-857. PubMed ID: 34286518
    [Abstract] [Full Text] [Related]

  • 9. Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells.
    Song L, Coppola D, Livingston S, Cress D, Haura EB.
    Cancer Biol Ther; 2005 Mar 15; 4(3):267-76. PubMed ID: 15753661
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells.
    Yan J, Zhong N, Liu G, Chen K, Liu X, Su L, Singhal S.
    Cell Death Dis; 2014 Jul 03; 5(7):e1316. PubMed ID: 24991768
    [Abstract] [Full Text] [Related]

  • 12. Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer.
    Ding Q, He X, Xia W, Hsu JM, Chen CT, Li LY, Lee DF, Yang JY, Xie X, Liu JC, Hung MC.
    Cancer Res; 2007 May 15; 67(10):4564-71. PubMed ID: 17495324
    [Abstract] [Full Text] [Related]

  • 13. Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway.
    Yang L, Zhou F, Zhuang Y, Liu Y, Xu L, Zhao H, Xiang Y, Dai X, Liu Z, Huang X, Wang L, Zhao C.
    Br J Cancer; 2021 Feb 15; 124(3):645-657. PubMed ID: 33122847
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA.
    Nie P, Hu W, Zhang T, Yang Y, Hou B, Zou Z.
    Cell Physiol Biochem; 2015 Feb 15; 35(6):2255-71. PubMed ID: 25895606
    [Abstract] [Full Text] [Related]

  • 16. Phenethyl isothiocyanate synergistically induces apoptosis with Gefitinib in non-small cell lung cancer cells via endoplasmic reticulum stress-mediated degradation of Mcl-1.
    Zhang Q, Chen M, Cao L, Ren Y, Guo X, Wu X, Xu K.
    Mol Carcinog; 2020 Jun 15; 59(6):590-603. PubMed ID: 32189414
    [Abstract] [Full Text] [Related]

  • 17. A Novel 3-Benzyloxychromone From Celastrus orbiculatus Thunb. Exhibits Anticancer Effects on Non-Small Cell Lung Cancer Cells via GSK-3β-Dependent c-Jun/ATF2 Pathway.
    Ding Y, Wang T, Xu Z, Fu Y, Liu Y, Tao L.
    Cell Biochem Funct; 2024 Sep 15; 42(7):e4120. PubMed ID: 39215681
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enhanced apoptotic effects by downregulating Mcl-1: evidence for the improvement of photodynamic therapy with Celecoxib.
    Song J, Chen Q, Xing D.
    Exp Cell Res; 2013 Jun 10; 319(10):1491-504. PubMed ID: 23524145
    [Abstract] [Full Text] [Related]

  • 20. Monosaccharide digitoxin derivative sensitize human non-small cell lung cancer cells to anoikis through Mcl-1 proteasomal degradation.
    Pongrakhananon V, Stueckle TA, Wang HL, O'Doherty GA, Dinu CZ, Chanvorachote P, Rojanasakul Y.
    Biochem Pharmacol; 2014 Mar 01; 88(1):23-35. PubMed ID: 24231508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.